慢性阻塞性肺病是否会影响冠状动脉旁路移植后的结果? 一项基于德国人口的回顾性研究
Nadine Hochhausen1, Marjolijn C Sales2, Natasja W M Ramnath2
1Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany.
Journal of clinical medicine
|September 14, 2024
概括
患有慢性阻塞性肺病 (COPD) 的患者在冠状动脉旁路移植 (CABG) 后经历了更糟糕的结果. 无冠状动脉绕道 (OPCAB) 手术和无心肺绕道 (CPB) 的微创心肺动脉置手术显示,COPD患者的结果有所改善.
科学领域:
- 心血管外科心血管外科
- 肺部医学 肺部医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 慢性阻塞性肺病 (COPD) 与冠状动脉旁路移植 (CABG) 后的结果之间的关系仍然是争论的主题.
- 了解这些相互作用对于优化患有并存疾病的患者手术策略至关重要.
研究的目的:
- 为了比较患有COPD和没有COPD的非紧急CABG患者的住院死亡率,住院时间 (HLOS) 和术后通风时间 (VT).
- 评估非抽动冠状动脉绕道 (OPCAB) 与抽动冠状动脉绕道 (ONCAB) 以及带有或没有心肺绕道 (CPB) 的最小侵入性CABG技术对COPD患者的结果的影响.
主要方法:
- 2015年至2021年期间在德国进行的非紧急CABG手术的基于人口的回顾性分析.
- 纳入了274,792名患者,特别关注的是与COPD患者和没有COPD患者之间的结果比较.
- 进行了子组分析,以评估COPD患者的OPCAB,ONCAB和具有/没有CPB的微创性CABG的影响.
主要成果:
- 与非COPD患者相比,COPD患者 (队列中的7.7%) 的住院死亡率显着更高 (6.0%与4.2%相比),HLOS更长 (13与12天相比),VT增加 (33与28小时相比).
- 与ONCAB相比,在COPD患者中,OPCAB手术与较低的住院死亡率 (3.5%与6.4%相比),较短的HLOS (12与13天相比) 和减少的VT (20与36小时相比) 相关.
- 在COPD患者中,没有CPB的最小侵入性CABG与CPB的最小侵入性CABG相比,导致较低的住院死亡率 (3.5%vs16.5%) 和较短的静脉治疗 (20vs65小时). 回归分析证实了在COPD患者中使用CPB的有害影响.
结论:
- 慢性肺炎与非紧急CABG后的不良结果有关.
- 无冠状动脉绕道 (OPCAB) 手术和无心肺绕道 (CPB) 的微创性冠状动脉绕道 (CABG) 似乎是接受CABG的COPD患者的有益策略.
- 需要进一步的研究来验证这些发现,并完善这种患者群体的外科推.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K